Download PDF
Der Nuklearmediziner 2014; 37(04): 250-253
DOI: 10.1055/s-0034-1385901
Pädiatrische Nuklearmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Diagnostische Wertigkeit der 18F-FDG-PET und MRT bei frühkindlicher Histiozytose

The Diagnostic Value of 18F-FDG PET and MRI in Paediatric Histiocytosis
W. P. Fendler
1   Klinik und Poliklinik für Nuklearmedizin, Ludwig-Maximilians-Universität München
,
T. Pfluger
1   Klinik und Poliklinik für Nuklearmedizin, Ludwig-Maximilians-Universität München
› Author Affiliations
Further Information

Publication History

Publication Date:
24 November 2014 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Es wird in diesem Übersichtsartikel die diagnostische Wertigkeit der 18F-Fluorodeoxyglucose-Positronenemissionstomografie (18F-FDG-PET) und Magnetresonanztomografie (MRT) für die Beurteilung der frühkindlichen Histiozytose dargestellt. Dabei werden Studien verglichen, die die Genauigkeit der 18F-FDG-PET und MRT untersuchten. Es zeigt sich ein Vorteil der 18F-FDG-PET in der Beurteilung der Tumoraktivität nach Chemotherapie. Die MRT zeigt eine höhere Sensitivität bei der Primärdiagnostik sowie bei der Beurteilung des intrazerebralen Befalls. Die kombinierte PET/MRT hat das Potenzial, die Vorteile beider Modalitäten in einem Untersuchungsdurchlauf zu verbinden.

Abstract

To analyze the diagnostic value of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) and magnetic resonance imaging for the evaluation of paediatric Langerhans cell histiocytosis. Results from different studies on the diagnostic accuracy of both modalities are compared. Our analysis suggests an important role of 18F-FDG PET for lesion follow-up after chemotherapy. MRI showed a higher sensitivity at primary diagnosis and is indispensable for evaluation of brain involvement. Simultaneous whole body PET/MRI acquisition may have the potential to combine the advantages of both modalities in one examination.

Schlüsselwörter

Histiozytose - FDG - PET - MRT - Wertigkeit

Key words

histiocytosis - FDG - PET - MRI - diagnostic value
 

  • Literatur

  • 1 Azouz EM, Saigal G, Rodriguez MM et al. Langerhans’ cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 2005; 35: 103-115
    CrossrefPubMedSearch in Google Scholar
  • 2 Binkovitz LA, Olshefski RS, Adler BH. Coincidence FDG-PET in the evaluation of Langerhans’ cell histiocytosis: preliminary findings. Pediatr Radiol 2003; 33: 598-602
    CrossrefPubMedSearch in Google Scholar
  • 3 Blum R, Seymour JF, Hicks RJ. Role of 18FDG-positron emission tomography scanning in the management of histiocytosis. Leuk Lymphoma 2002; 43: 2155-2157
    CrossrefPubMedSearch in Google Scholar
  • 4 Buchler T, Cervinek L, Belohlavek O et al. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine. Pediatr Blood Cancer 2005; 44: 286-288
    CrossrefPubMedSearch in Google Scholar
  • 5 Drzezga A, Souvatzoglou M, Eiber M et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 2012; 53: 845-855 [pii]10.2967/jnumed.111.098608
    CrossrefPubMedSearch in Google Scholar
  • 6 Gadner H, Grois N, Arico M et al. A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis. J Pediatr 2001; 138: 728-734 [pii] 10.1067/mpd.2001.111331
    CrossrefPubMedSearch in Google Scholar
  • 7 Gadner H, Grois N, Potschger U et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2008; 111: 2556-2562 [pii] 10.1182/blood-2007-08-106211
    CrossrefPubMedSearch in Google Scholar
  • 8 Grois N, Fahrner B, Arceci RJ et al. Central nervous system disease in Langerhans cell histiocytosis. J Pediatr 2010; 156: 873-881 81 e1 [pii] 10.1016/j.jpeds.2010.03.001
    CrossrefPubMedSearch in Google Scholar
  • 9 Grois N, Potschger U, Prosch H et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 2006; 46: 228-233
    CrossrefPubMedSearch in Google Scholar
  • 10 Grois N, Tsunematsu Y, Barkovich AJ et al. Central nervous system disease in Langerhans cell histiocytosis. Br J Cancer Suppl 1994; 23: S24-S28
    PubMedSearch in Google Scholar
  • 11 Goo HW, Yang DH, Ra YS et al. Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy. Pediatr Radiol 2006; 36: 1019-1031
    CrossrefPubMedSearch in Google Scholar
  • 12 Hoover KB, Rosenthal DI, Mankin H. Langerhans cell histiocytosis. Skeletal Radiol 2007; 36: 95-104
    CrossrefPubMedSearch in Google Scholar
  • 13 Kaste SC, Rodriguez-Galindo C, McCarville ME et al. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 2007; 37: 615-622
    CrossrefPubMedSearch in Google Scholar
  • 14 Kellenberger CJ, Epelman M, Miller SF et al. Fast STIR whole-body MR imaging in children. Radiographics 2004; 24: 1317-1330 24/5/1317 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 15 Kilborn TN, Teh J, Goodman TR. Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings. Clin Radiol 2003; 58: 269-278 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 16 Krajicek BJ, Ryu JH, Hartman TE et al. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Chest 2009; 135: 1542-1549 [pii]10.1378/chest.08-1899
    CrossrefPubMedSearch in Google Scholar
  • 17 Lee HJ, Ahn BC, Lee SW et al. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis. Ann Nucl Med
    PubMed
  • 18 Mentzel HJ, Kentouche K, Sauner D et al. Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 2004; 14: 2297-2302
    CrossrefPubMedSearch in Google Scholar
  • 19 Meyer JS, De Camargo B. The role of radiology in the diagnosis and follow-up of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 307-326
    CrossrefPubMedSearch in Google Scholar
  • 20 Minkov M, Grois N, Heitger A et al. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol 2002; 39: 581-585
    CrossrefPubMedSearch in Google Scholar
  • 21 Mueller WP, Melzer HI, Schmid I et al. The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis. Eur J Nucl Med Mol Imaging 2013; 40: 356-363
    CrossrefPubMedSearch in Google Scholar
  • 22 Ohno Y, Koyama H, Yoshikawa T et al. Pulmonary magnetic resonance imaging for airway diseases. J Thorac Imaging 2011; 26: 301-316 00005382-201111000-00007 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 23 Pavlik M, Bloom DA, Ozgonenel B et al. Defining the role of magnetic resonance imaging in unifocal bone lesions of langerhans cell histiocytosis. J Pediatr Hematol Oncol 2005; 27: 432-435 [pii]
    CrossrefPubMedSearch in Google Scholar
  • 24 Phillips M, Allen C, Gerson P et al. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009; 52: 97-101
    CrossrefPubMedSearch in Google Scholar
  • 25 Schmidt S, Eich G, Geoffray A et al. Extraosseous langerhans cell histiocytosis in children. Radiographics 2008; 28: 707-726 quiz 910-9111 [pii]10.1148/rg.283075108
    CrossrefPubMedSearch in Google Scholar